Gold Nanoparticle-Assisted Virus Formation by Means of the Delivery of an Oncolytic Adenovirus Genome
Nanomaterials (Basel). 2020 Jun 17;10(6):1183. doi: 10.3390/nano10061183.ABSTRACTOncolytic…
Effect of Transgene Location, Transcriptional Control Elements and Transgene Features in Armed Oncolytic Adenoviruses
Cancers (Basel). 2020 Apr 23;12(4):1034. doi: 10.3390/cancers12041034.ABSTRACTClinical…
Targeted biopsies using magnetic resonance imaging/ultrasonograpgy fusion compared with sistematic biopsies prostate cancer detection. Initial experience.
Arch Esp Urol. 2020 Apr;73(3):192-201.ABSTRACTOBJECTIVE: To describe…
Sensitivity of cervico-vaginal cytology in endometrial carcinoma: A systematic review and meta-analysis
Cancer Cytopathol. 2020 Nov;128(11):792-802. doi: 10.1002/cncy.22266.…
Incidence and characteristics of neurotoxicity in immune checkpoint inhibitors with focus on neuromuscular events: Experience beyond the clinical trials
J Peripher Nerv Syst. 2020 Jun;25(2):171-177. doi: 10.1111/jns.12371.…
Association Between Second Progression-free Survival (PFS2) and Overall Survival in Metastatic Castration-resistant Prostate Cancer
Eur Urol. 2020 Jun;77(6):763-766. doi: 10.1016/j.eururo.2020.02.025.…
Non-BRCA DNA Damage Repair Gene Alterations and Response to the PARP Inhibitor Rucaparib in Metastatic Castration-Resistant Prostate Cancer: Analysis From the Phase II TRITON2 Study
Clin Cancer Res. 2020 Jun 1;26(11):2487-2496. doi: 10.1158/1078-0432.CCR-20-0394.…
First-in-Human, First-in-Child Trial of Autologous MSCs Carrying the Oncolytic Virus Icovir-5 in Patients with Advanced Tumors
Mol Ther. 2020 Apr 8;28(4):1033-1042. doi: 10.1016/j.ymthe.2020.01.019.…
T-Type Calcium Channels as Potential Therapeutic Targets in Vemurafenib-Resistant BRAFV600E Melanoma
J Invest Dermatol. 2020 Jun;140(6):1253-1265. doi: 10.1016/j.jid.2019.11.014.…
Pembrolizumab for Treatment-Refractory Metastatic Castration-Resistant Prostate Cancer: Multicohort, Open-Label Phase II KEYNOTE-199 Study
J Clin Oncol. 2020 Feb 10;38(5):395-405. doi: 10.1200/JCO.19.01638.…
Intratumor Adoptive Transfer of IL-12 mRNA Transiently Engineered Antitumor CD8+ T Cells
Cancer Cell. 2019 Dec 9;36(6):613-629.e7. doi: 10.1016/j.ccell.2019.10.006.…
Corrigendum to ‘Chemotherapy and PARP inhibitors in heavily pretreated BRCA1/2 mutation ovarian cancer (BMOC) patients’ [Gynecologic Oncology 152 (2019) 270-277]
Gynecol Oncol. 2020 Jan;156(1):262. doi: 10.1016/j.ygyno.2019.10.020.…
